Metabolic shift or enhanced glutamine metabolism is believed to occur in response to oncogenes such as c-MYC and pro-inflammatory cytokines in glioblastoma [22] However, the exact mechanism by which this occurs is not fully understood in glioblastoma [23]. The gene discussed is MYC; the disease is glioblastoma.